Showing 7891-7900 of 9516 results for "".
Modifying Masseters and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/modifying-masseters-and-more/19698/Artful use of neurotoxin in the masseters and parotid glands can help thin the appearance of the face. Chytra Anand, MD discusses her approach and talks about treatments used in her home country of India.Psoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic frBeautiFill™: One Step Fat Transfer Solution
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/beautifill-one-step-fat-transfer-solution/19550/Sponsored by AlmaNew Toxin Textbook Hits Shelves
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-toxin-textbook-hits-shelves/18321/Available at Wiley-Blackwell and on Amazon.com, “Botulinum Toxins: Cosmetic and Clinical Applications” offers up-to-date info on neuromodulators in the US and abroad, along with tips on how to use them on the face and body. Joel Cohen, MD shares details about his new textbook.Updates from CSF 2017
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,Derm Surgeries Top 10M; VCS Kicks Off; Tildrakizumab with FDA
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-derm-surgeries-top-10m-vcs-kicks-off-tildrakizumab-with-fda/18468/Dermatologic surgical procedures continue to increase in popularity. Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016—up five percent from 2015 and up 31 percent since 2012. Results are presented in the 2016 American Society for Dermatologic SurMid-Face Filler Pearls
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/mid-face-filler-pearls/18537/Shannon Humphrey, MD shares three pearls for avoiding the filler complication patients fear the most in the mid-face: unnatural results. You must have a plan, she says, to avoid treating the cheeks as an island rather than as part of the full face.Humphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needsMake The Experience Unforgettable
https://practicaldermatology.com/topics/practice-management/make-the-experience-unforgettable/18583/When practices looking for ways to differentiate should focus on creating amazing experiences, says Robert Rullo. One important consideration is the person answering your phones, who needs to convey your expertise and your story.Valeant's Plan for Derm; VCS Highlights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-valeant-s-plan-for-derm-vcs-highlights/18587/Amid reports that its Obagi and Solta units may be sold off, Valeant Pharmaceuticals is assuring investors that the company is focused on the future and has plans to fix its dermatology unit. Vegas Cosmetic Surgery has wrapped up its 12th program, gathering dermatologists, plastic surgeons, facial p